Eyre Brik V 4
4 · BAXTER INTERNATIONAL INC · Filed May 10, 2018
Insider Transaction Report
Form 4
Eyre Brik V
CVP, Hospital Products
Transactions
- Sale
Common Stock, $1 par value
2018-05-08$69.61/sh−36,359$2,530,950→ 65,115 total - Exercise/Conversion
Common Stock, $1 par value
2018-05-08$37.38/sh+20,000$747,600→ 101,474 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-08−4,414→ 0 totalExercise: $37.38From: 2016-03-03Exp: 2025-03-03→ Common Stock, $1 par value (4,414 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-08−15,586→ 35,828 totalExercise: $37.38From: 2017-03-03Exp: 2025-03-03→ Common Stock, $1 par value (15,586 underlying)
Footnotes (3)
- [F1]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eyre with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Eyre.
- [F2]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eyre with respect to certain vested stock options and restricted stock units previously granted by BII to Mr. Eyre.
- [F3]Price reflects weighted average sales price. Range of prices for transactions are $63.31 through $70.15. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request.